Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $87.2 million.

  • Kyntra Bio's Cash from Investing Activities rose 1144437.09% to $87.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.9 million, marking a year-over-year decrease of 3394.34%. This contributed to the annual value of $126.0 million for FY2024, which is 1800.37% down from last year.
  • Kyntra Bio's Cash from Investing Activities amounted to $87.2 million in Q3 2025, which was up 1144437.09% from -$13000.0 recorded in Q2 2025.
  • Kyntra Bio's Cash from Investing Activities' 5-year high stood at $103.5 million during Q1 2023, with a 5-year trough of -$196.7 million in Q1 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was $1.7 million (2024), whereas its average is $1.5 million.
  • As far as peak fluctuations go, Kyntra Bio's Cash from Investing Activities crashed by 45122.75% in 2021, and later surged by 1144437.09% in 2025.
  • Quarter analysis of 5 years shows Kyntra Bio's Cash from Investing Activities stood at -$50.6 million in 2021, then surged by 102.16% to $1.1 million in 2022, then soared by 837.05% to $10.2 million in 2023, then plummeted by 83.18% to $1.7 million in 2024, then skyrocketed by 4958.62% to $87.2 million in 2025.
  • Its Cash from Investing Activities stands at $87.2 million for Q3 2025, versus -$13000.0 for Q2 2025 and -$16000.0 for Q1 2025.